Last updated on May 2015

Risperidone-controlled Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia


Brief description of study

This research is a Randomized, double-blind, risperidone-controlled, multicenter clinical study. Chinese subjects with Ischemic Schizophrenia.

Detailed Study Description

Subjects will randomly enter into one of two groups,the period of treatment is 8 weeks.

Clinical Study Identifier: NCT02453893

Contact Investigators or Research Sites near you

Start Over

Li Hua fang, Ph.D

Shanghai Mental Health Center
Shanghai, China
  Connect »